1. Enforcement policy for extracorporeal membrane oxygenation and cardiopulmonary bypass devices during the Coronavirus disease 2019 (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff Publication: [Silver Spring, MD] : Center for Devices and Radiological Health, Office of Product Evaluation and Quality April 2020 Subject(s): Cardiopulmonary Bypass -- instrumentationExtracorporeal Membrane Oxygenation -- instrumentationCOVID-19 -- therapyUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
